Abstract The purpose of this study was to use a retrospective nonlinear distortion correction technique and evaluate the changes in DTI metrics in areas of interest in and around GBM tumors. A total of 24 histologically confirmed GBM patients with pre-operative 20-direction DTI scans were examined. Variability in apparent diffusion coefficient (ADC) and fractional anisotropy (FA) in normal tissue before and after distortion correction were examined. Changes in mean, median and variance of ADC and FA in contrast enhancing and T2/FLAIR ROIs were also examined with and without distortion correction. Results suggest the intra-subject SDs of ADC and FA decreased in normal tissue after the application of distortion correction (P \ 0.0001). FA mean and median values decreased after distortion correction in both T1?C and T2 ROIs (P \ 0.017), while ADC mean and median values did not significantly change except for the median ADC in T1?C ROIs (P = 0.0054). The intra-subject SD of ADC and FA values in tumor ROIs changed significantly with distortion correction, and Bland-Altman analysis indicated that the bias and the SD of the bias of these intra-subject SDs were larger than those of the mean and median terms. Additionally, the means of the two curves of a double Gaussian fit to the histogram of ADC values from T1?C ROIs, ADC L (mean of lower Gaussian) as well as ADC H (mean of the higher Gaussian) were found to change significantly with distortion correction (P = 0.0045 for ADC L and P = 0.0370 for ADC H ). Nonlinear distortion correction better aligns neuro-anatomical structures between DTI and anatomical scans, and significantly alters the measurement of values within tumor ROIs for GBM patients.
Introduction
Glioblastoma multiforme (GBM) is the most aggressive form of primary brain tumor with low median survival time of 14.6 months using radiotherapy and temozolomide [1] . Infiltration along white matter (WM) tracts and subsequent proliferation of tumor cells result in both local and distal recurrence, altering the extracellular matrix and local biological environment [2, 3] . Diffusion tensor imaging (DTI) is a magnetic resonance imaging technique that can be used to probe sub-voxel extracellular microstructure and potentially elicit insight regarding proliferation and infiltration behavior in GBMs. Although controversial, the apparent diffusion coefficient (ADC), a quantity that describes the magnitude of water diffusion, has shown sensitivity to tumor cellularity [4] [5] [6] , aggressiveness [7, 8] , and response to therapies [9, 10] . Fractional anisotropy (FA), a quantitative measure of diffusion anisotropy derived from DTI, has shown sensitivity to tumor infiltration and proliferation [11] [12] [13] [14] , and is used routinely for preoperative delineation of tumors for resection [15] . However, acquisition of diffusion MR images is prone to geometric distortions from differences in magnetic susceptibility at tissue boundaries [16] . These geometric distortions may lead to inaccurate stereotactic placement of tumor and resulting in imprecise quantitative measurements as well as resection boundaries.
Retrospectively, geometric distortion correction of DTI data can be performed using nonlinear registration of the reference (b = 0) image of the DTI dataset with geometric distortions to an anatomical image, and then applying this transformation to rest of the raw DTI data [17, 18] . In the current study we tested whether retrospective, nonlinear distortion correction of DTI data would result in improved anatomical alignment of DTI to anatomical images, reduced variability in FA and ADC measurements within tumor tissue, and altered DTI measurements of tumor characteristics when compared to standard DTI measurement techniques.
Materials and methods

Patient population
Patients were retrospectively selected from our neurooncology database. All patients signed appropriate institute review board approved consent forms, and image acquisition and processing was performed in conformance with the Health Insurance Portability and Accountability Act (HIPAA) regulations. A total of n = 24 subjects were selected based on the following criteria: (1) newly diagnosed (no previous treatments) and pathologically confirmed GBM, (2) uniformly collected high quality preoperative, 20 direction DTI scans, and (3) high quality anatomical T2 and T1 post-contrast scans. Patient scan dates spanned from August 8th, 2009, to December 11th, 2011. Patient age at time of scan was 64 ± 13 years (mean ± SD). At the time of last assessment (October 8th 2012), 14 of the 24 patients were deceased.
MRI
All images were collected on either a 1.5T Siemens Avanto or 3-T Siemens Tim Trio (Siemens Medical, Erlangen, Germany) MR system using sequences supplied by the scanner manufacturer. A total of 6 subjects had images collected on a 1.5T scanner and 18 had images collected on a 3T scanner. Anatomical T2 and gadopentetate dimeglumine enhanced (Magnevist; Berlex; 0.1 mmol/kg) axially acquired 3D T1-weighted volumetric images were acquired. DTI scans were obtained with the following scan parameters: TE/TR = 84-100 ms/9,400-1,2900 ms, NEX = 1, slice thickness = 2 mm with no interslice gap, matrix size = 128 9 128, and FOV = 25.6 cm giving a 2 9 2 9 2 mm 3 voxel size with one b = 0 mm 2 /s and 20 b = 1000 mm 2 /s images in non-collinear directions.
Non-corrected DTI estimation DTI data was re-constructed using FDT, FMRIB's Diffusion Toolbox in FSL [19] (http://fsl.fmrib.ox.ac.uk/fsl/ fslwiki/FDT). First, the data was corrected for eddy currents and bulk motion using FSL. The 3 9 3 2nd order diffusion tensor field, ADC, and FA were then estimated using FSL. DTI metrics were resampled to the resolution of the anatomical T2 images using tri-linear interpolation implemented in the Analysis of Functional NeuroImages (AFNI) software package (http://afni.nimh.nih.gov/afni/). The resulting DTI-derived maps were then used for subsequent analyses.
Distortion-corrected DTI estimation
Distortion corrected DTI data were calculated using FSL's linear (FLIRT) and nonlinear (FNIRT) registration tools. First, eddy current correction was performed using FDT's eddy current correction. Then, the non-diffusion-weighted b = 0 s/mm 2 image was linearly registered to the anatomical T2 image using FLIRT with a 12-degree of freedom transformation and mutual information cost function. Next, nonlinear registration was used to warp the registered b = 0 s/mm 2 image to the anatomical T2-weighted image using a free-form deformation algorithm with a B-spline basis function available using FNIRT [20, 21] . Linear registration matrices and nonlinear warp fields were then applied to the subsequent DTI data series, producing ''corrected'' ADC and FA maps.
Regions of interest
Contrast enhancement on post-contrast T1-weighted images (T1?C) and T2 hyperintense regions of interest (ROIs) were examined in the current study. First, anatomical post-contrast 3D T1-weighted images were aligned and resampled to the resolution of T2-weighted images. Then, T1?C or T2 hyperintense ROIs were selected using a semi-automated process of: (1) manually isolating the general region of interest to areas of suspected tumor, (2) applying a case-by-case threshold to isolate T1?C or T2 lesions, and then (3) manually editing the resulting masks to exclude any errors.
Normal-appearing tissue ROIs were selected by applying FMRIB's automated segmentation tool, FAST [22] (http:// fsl.fmrib.ox.ac.uk/fsl/fslwiki/FAST) to T1-weighted images to segment cerebrospinal fluid (CSF), gray matter (GM) and WM using a hidden Markov random field model along with an Expectation-Maximization algorithm and excluding any regions of tumor. Normal-appearing tissue ROIs were then visually checked for accurate segmentation (Fig. 1b, h ).
ADC histogram analysis
ADC histogram analysis was performed using techniques described elsewhere [23, 24] . Briefly, ADC values using both techniques (corrected and non-corrected) were extracted from contrast-enhancing image voxels. Then, a histogram was formed using bin spacing of 0.05 um 2 /ms and a double Gaussian mixed model was fit to the histogram data using nonlinear regression in GraphPad Prism version 4.0c (GraphPad Software, Inc., La Jolla, CA). The double Gaussian model was defined as: p(ADC) = fÁN(l ADCL ,r ADCL ) ? (1 -f)ÁN(l ADCH ,r ADCH ), where p(ADC) is the probability of obtaining a particular value of ADC in the histogram, f is the relative proportion of voxels represented by the lower histogram, N(l,r) represents a normal (Gaussian) distribution with mean l and SD r, ADC L represents the mean of the lower and ADC H represents the mean of the larger of the two Gaussian distributions. The accuracy of model fits was manually examined to exclude erroneous results. In some cases regression was re-run with different initial conditions until convergence was obtained.
Hypothesis testing
To test whether nonlinear distortion-correction would improve alignment between DTI data and anatomical images we compared intra-subject SDs of FA and ADC values in each tissue type before and after distortion-correction using Wilcoxon matched-pairs signed rank tests, postulating that the variability in ADC and FA would be reduced because of better alignment. To test whether measurements of tumor FA and ADC change after distortion-correction in regions severely affected by geometric distortions we compared the uncorrected and distortioncorrected mean, median and SD within T2 and T1?C ROIs for both FA and ADC using a Wilcoxon matched-pairs signed rank tests. For ADC histogram analysis, we compared uncorrected and distortion-corrected estimates of ADC L and ADC H via Wilcoxon matched-pairs signed rank tests, as well as performing Bland-Altman tests. We also compared the differences between uncorrected and distortion corrected values extracted from each different ROI when adjusted for field strength (1.5T and 3T) using Bonferroni corrected Mann-Whitney tests to determine the effect field strength on distortion correction.
Results
In general, distortion-correction tended to better align DTI data to neuroanatomical structures in the T2 and highresolution post contrast T1-weighted images as defined in regions near the ventricles, WM tracts, peritumoral edematous regions, and contrast-enhancing tumor regions. In most cases distortion correction either improved alignment or maintained adequate alignment if original DTI data were relatively distortion free. Without distortion correction, contrast-enhancing regions of interest were often misaligned and included necrotic tissue (high ADC, low FA) and adjacent normal-appearing tissue (Fig. 1) . This qualitative observation was verified by comparing the SD of FA (Fig. 2a) and ADC (Fig. 2b) (Table 1 ). Similar to T1?C ROIs, median, mean, and SD of FA values within T2 hyperintense lesions were also significantly reduced after distortion correction (Table 1) ; however, only SD in ADC were significantly different between distortion-corrected and uncorrected ADC values within T2 hyperintense ROIs (Table 1) .
Bland-Altman analysis revealed that ADC values tended to increase (positive bias), FA values tended to decrease (negative bias), and the SD of these values tended to decrease (negative bias) after distortion-correction ( Table 1 ). The increase in ADC median and mean values was relatively small within both T1?C (1.6 and 0.08 %, respectively) and T2 hyperintense ROIs (0.57 and 0.47 %, respectively), suggesting distortion-correction may only result in subtle changes in mean or median ADC measurement. The decrease in FA was more dramatic, showing median and mean FA within T1?C ROIs decreasing 6.8 and 6.3 %, respectively, and median and mean FA within T2 hyperintense ROIs decreasing 4.9 and 6.5 %, respectively. Although median and mean DTI measurements were only modestly affected by nonlinear distortion correction, SD in ADC and FA, within both T1?C and T2 hyperintense ROIs, demonstrated substantial decreases in variability. For example, SD of ADC measurements within T1?C and T2 hyperintense ROIs reduced approximately 20 and 13 %, respectively. Similarly, SD of FA measurements in T1?C and T2 hyperintense ROIs reduced approximately 8.5 and 11 %, respectively. When comparing the difference between uncorrected and distortion corrected values in subjects scanned on either a 1.5T or 3T scanner Bonferroni corrected Mann-Whitney tests suggested significant differences in intra-subject SD of ADC in cerebrospinal fluid (P = 0.0069), but no significant differences in other parameters. Together, these results suggest ADC and FA values, as well as the variability in these measures, are significantly altered as a result of distortion correction.
Lastly, we examined how nonlinear distortion correction of DTI data might affect ADC histogram analysis (Fig. 3) . Results indicated that both ADC L and ADC H appeared altered as a result of distortion correction ( Fig. 3c, d ; Wilcoxon Matched-Pairs Signed Rank, P = 0.0045 for ADC L and P = 0.0370 for ADC H ). ADC L tended to have a low variability (SD of bias of 4.1 %) across all ADC L values and positive bias of 2.4 %; whereas variations in ADC H were larger (SD of bias of 15 %) and tended to decrease (bias of -4.4 %) after distortion correction (Fig. 3e, f) . Figure 3a , b illustrates an example of how ADC histograms changed as a result of distortion correction. In particular, without distortion correction the T1?C ROIs tend to have a well-defined second Gaussian distribution (ADC H ), while after distortion correction this distribution was less pronounced and almost could be characterized using a single Gaussian distribution. These results appear to demonstrate that most of the information captured in the higher Gaussian distribution may be the result of misalignment due to geometric distortion of ADC maps. 
Discussion
Quantitative measurements of ADC [4, 23, 24] and FA [11] [12] [13] [14] derived from DTI have demonstrated the ability to be useful imaging biomarkers for characterizing malignancy and predicting prognosis in patients with glioblastoma. Severe geometric distortion in these scans, however, can complicate the interpretation of these data and may misrepresent underlying microstructural features. In the current study we implemented a simple nonlinear distortion correction technique for retrospectively correcting geometric distortions associated with DTI data and demonstrated that distortion-correction may significantly alter anatomical alignment and diffusion measurements in glioblastoma. We believe this improved anatomical alignment more correctly captures the DTI signal coming from the actual tumor or peritumoral voxels, and thus samples a more homogenous tissue (tumor) and excludes contamination from voxels of other tissue types (normal tissue), though this hypothesis needs histological verification.
Results from the current study showed modest reductions in the average FA within tumor regions, while average ADC changes appeared subtler. This systematic decrease in FA values, but not in ADC values, was also reported by Kim et al. [25] and was attributed to geometric distortions in uncorrected DTI data resulting in artificially increasing the FA. While average ADC appeared to be relatively robust and only exhibit small changes after distortion correction, variance in both ADC and FA were dramatically reduced. This reduction in variability in DTI parameters suggests nonlinear distortion correction may result in selection of more homogeneous tissue within ROIs, whereas uncorrected ROIs may contain a variety of tissue types from misalignment of DTI data to the underlying anatomical data.
Additionally, our results showed that ADC L changed significantly with geometric distortions in the DTI data, and ADC H measurements changed even more drastically with the presence of distortion. Interestingly, Pope et al. [23, 24] found that pre-treatment ADC L values, but not ADC H values, within contrast-enhancing ROIs could predict response to bevacizumab, a potent anti-angiogenic agent. Results from the current study suggest the lack of predictability in ADC H measurements may in part be due to the presence of geometric distortions in the underlying DWI data; however, future studies aimed at testing whether distortion correction can improve the predictability of ADC histogram analysis in glioblastoma are warranted.
While a few parameters are known to affect the degree of distortion in DTI scans, such as field strength and position of certain structures, we only observed a significant difference in the intra-subject SD of ADC values in CSF when accounting for fields strength; however, this effect may be more pronounced when examining a larger cohort of patients. Similarly, we expect the degree of distortion to be highly dependent o the location of the tumor within the brain. Since the purpose of the current study was to examine the effects of distortion correction on DTI measurements and not to quantify the magnitude of distortion on diffusion images across the topography of the brain, the small sample size and nonuniform distribution of tumors throughout the brain did not make this type of analysis possible in the current study. The effect of tumor location on the magnitude of distortion remains an important unanswered question that requires further investigation.
A few potential limitations in the current study should be addressed. In the current study we chose to use the FNIRT nonlinear registration tool; however, a variety of other distortion-correction algorithms have been developed. Another potential limitation is the relatively small sample size in the current study; however, the use of 24 patients for purposes of demonstrating improved quantitation using nonlinear distortion correction appeared to be adequate.
Although nonlinear distortion correction of diffusion MRI data is relatively well accepted in the MR imaging community, it is not typically incorporated into the clinical evaluation of brain tumors. Our data suggests a relatively simple step of posthoc nonlinear distortion correction of diffusion MRI data increases the alignment between DTI and structural MRI scans, allowing us to improve our ability to more accurately measure diffusion MR parameters, and furthering our understanding of their application neuro-oncology clinical practice.
